Transgene Biotek Ltd Performance
Day's Low
Day's High
₹7.03₹7.6652 Week's Low
52 Week's High
₹5.79₹12.46
| Returns % | |
| 1 Month Return | + 8.81 % |
| 3 Month Return | -5.08 % |
| 1 Year Return | -25.2 % |
| Market Stats | |
| Previous Close | ₹7.66 |
| Open | ₹7.66 |
| Volume | 38.39K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹58.04Cr |
Transgene Biotek Ltd Key Statistics
| P/E Ratio | -191.5 |
| PEG Ratio | -517.57 |
| Market Cap | ₹58.04 Cr |
| P/B Ratio | -8.95 |
| EPS | -0.09 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 0 |
Transgene Biotek Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹58.04 Cr | 47.19% | 1.11 | -₹1 Cr | NA | |
| NA | ₹217.55 Cr | 1.31% | 0.71 | ₹4 Cr | ₹84 Cr | |
| BUY | ₹16,694.59 Cr | 53.03% | 0.68 | ₹218 Cr | ₹1,296 Cr | |
| BUY | ₹1,508.50 Cr | -1.68% | 0.59 | ₹41 Cr | ₹337 Cr | |
| BUY | ₹2,640.51 Cr | 30.96% | 0.56 | ₹83 Cr | ₹933 Cr |
About Transgene Biotek Ltd
Share Price: ₹7.10 per share as on 12 Dec, 2024 04:01 PM
Market Capitalisation: ₹58.04Cr as of today
Revenue: ₹0.06Cr as on September 2024 (Q3 24)
Net Profit: ₹0.07Cr as on September 2024 (Q3 24)
Chairperson Name: K Koteswara Rao
| Organisation | Transgene Biotek Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Transgene Biotek Ltd
Transgene Biote Reports Mixed Financial Results - 28 Nov, 2024
Transgene Biote reported a 30% increase in net sales to Rs 0.06 crore for September 2024, but also a quarterly net loss of Rs 0.07 crore, up 44.65% year-on-year. The company's EBITDA remains negative. Shares closed at Rs 6.97, with a 9.25% return over six months but a decline of 19.33% over the past year.
Insights on Transgene Biotek Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Sep 2024 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Vimta Labs Ltd has given 117.0% return, outperforming this stock by 142.2%
- NO EFFECT
Against Peers
In the last 3 years, Shree Ganesh Remedies Ltd has given 126.8% return, outperforming this stock by 27.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 0.7 Cr → 0.1 Cr (in ₹), with an average decrease of 85.7% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 0.2 Cr → -0.07 Cr (in ₹), with an average decrease of 135.0% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 year, Transgene Biotek stock has moved down by -25.2%
Transgene Biotek Ltd Financials
Transgene Biotek Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 21.68% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 70.04% | 0.00 | |
| Others | 8.28% | 0.00 |
Transgene Biotek Ltd Key Indicators
Transgene Biotek Ltd Valuation
Transgene Biotek Ltd in the last 5 years
Lowest (-207.00x)
July 12, 2024
Today (-191.50x)
December 11, 2024
Industry (103.78x)
December 11, 2024
Highest (13.23x)
October 8, 2018
Transgene Biotek Ltd Technicals Summary
Bearish
Neutral
Bullish
Transgene Biotek Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Transgene Biotek Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Transgene Biotek Ltd shares.
Transgene Biotek Ltd (526139) share price today is ₹7.1
Transgene Biotek Ltd is not listed on NSE
Transgene Biotek Ltd is listed on BSE
- Today’s highest price of Transgene Biotek Ltd is ₹7.66.
- Today’s lowest price of Transgene Biotek Ltd is ₹7.03.
PE Ratio of Transgene Biotek Ltd is -191.5
PE ratio = Transgene Biotek Ltd Market price per share / Transgene Biotek Ltd Earnings per share
Today’s traded volume of Transgene Biotek Ltd(526139) is 38.39K.
Today’s market capitalisation of Transgene Biotek Ltd(526139) is ₹58.04Cr.
| Transgene Biotek Ltd(526139 | Price |
|---|---|
52 Week High | ₹12.46 |
52 Week Low | ₹5.79 |
Transgene Biotek Ltd(526139) share price is ₹7.1. It is down -43.02% from its 52 Week High price of ₹12.46
Transgene Biotek Ltd(526139) share price is ₹7.1. It is up 22.63% from its 52 Week Low price of ₹5.79
| Transgene Biotek Ltd(526139 | Returns |
|---|---|
1 Day Returns | -0.56% |
1 Month Returns | 8.81% |
3 Month Returns | -5.08% |
1 Year Returns | -25.2% |